XML 74 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings Per Common Share Attributable To Mylan Inc.
3 Months Ended
Mar. 31, 2013
Earnings Per Share [Abstract]  
Earnings per Common Share Attributable to Mylan Inc.
Earnings per Common Share Attributable to Mylan Inc.
Basic earnings per common share is computed by dividing net earnings attributable to Mylan Inc. common shareholders by the weighted average number of shares outstanding during the period. Diluted earnings per common share is computed by dividing net earnings attributable to Mylan Inc. common shareholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.
On September 15, 2008, concurrent with the sale of $575 million aggregate principal amount of Cash Convertible Notes due 2015 (the “Cash Convertible Notes”), Mylan entered into a convertible note hedge and warrant transaction with certain counterparties. Pursuant to the warrant transactions, the Company sold to the counterparties warrants to purchase in the aggregate up to approximately 43.2 million shares of Mylan common stock, subject to certain anti-dilution provisions. In 2011, the Company entered into amendments with the counterparties to exchange the original warrants with an exercise price of $20.00 (the “Old Warrants”) with new warrants with an exercise price of $30.00 (the “New Warrants”). Approximately 41.0 million of the Old Warrants were exchanged in the transaction. Both the Old and New Warrants meet the definition of derivatives under the FASB’s guidance regarding accounting for derivative instruments and hedging activities; however, because these instruments have been determined to be indexed to the Company’s own stock and meet the criteria for equity classification under the FASB’s guidance regarding contracts in an entity’s own equity, the warrants have been recorded in shareholders’ equity in the Condensed Consolidated Balance Sheets. The dilutive impact of the Old and New Warrants are included in the calculation of diluted earnings per share based upon the average market value of the Company’s common stock during the period as compared to the exercise price. For the three months ended March 31, 2013 and 2012, 0.7 million warrants and 0.2 million warrants, respectively, were included in the calculation of diluted earnings per share.
On February 27, 2013, the Board of Directors of the Company approved the repurchase of up to $500 million of the Company’s common stock in the open market. The repurchase program was completed during the first quarter of 2013 with approximately 16.3 million shares of common stock repurchased.
Basic and diluted earnings per common share attributable to Mylan Inc. are calculated as follows:
 
Three Months Ended
 
March 31,
(In thousands, except per share amounts)
2013
 
2012
Basic earnings attributable to Mylan Inc. common shareholders (numerator):
 
 
 
Net earnings attributable to Mylan Inc. common shareholders
$
106,882

 
$
129,079

Shares (denominator):
 
 
 
Weighted average common shares outstanding
393,163

 
427,251

Basic earnings per common share attributable to Mylan Inc. common shareholders
$
0.27

 
$
0.30


Diluted earnings attributable to Mylan Inc. common shareholders (numerator):
 
 
 
Net earnings attributable to Mylan Inc. common shareholders
$
106,882

 
$
129,079

Shares (denominator):
 
 
 
Weighted average common shares outstanding
393,163

 
427,251

Stock-based awards and warrants
5,850

 
5,114

Total dilutive shares outstanding
399,013

 
432,365

Diluted earnings per common share attributable to Mylan Inc. common shareholders
$
0.27

 
$
0.30


Additional stock options and restricted stock awards were outstanding during the periods ended March 31, 2013 and 2012 but were not included in the computation of diluted earnings per share for each respective period, because the effect would be anti-dilutive. Such anti-dilutive stock options or restricted stock awards represented 2.3 million and 6.4 million shares for the three months ended March 31, 2013 and 2012, respectively.